Mobile version of SCIRP

Scientific Research
An Academic Publisher

OPEN       ACCESS

Login
  • Home
  • Articles
  • Journals
  • Books
  • News
  • About
  • Submit
Home > Journals > Biomedical & Life Sciences | Medicine & Healthcare >Health
Health

Health

ISSN Print: 1949-4998
ISSN Online: 1949-5005
Website: https://www.scirp.org/journal/health
E-mail: health@scirp.org
Google-based Impact Factor: 0.86    
Citations     h5-index & Ranking*
Submission
  • Articles
  • Archive
  • Indexing
  • Aims & Scope
  • Editorial Board
  • For Authors
  • Publication Fees
"Regional Evaluation of Tolerability and Efficacy of Imatinib Mesylate in Patients with Chronic Phase CML in Mashhad (Iran, Southwest Asia)"
written by Zahra Mozaheb, Maeedeh Javani,
published by Health, Vol.6 No.10, 2014
has been cited by the following article(s):
  • Google Scholar
  • CrossRef
[1] Tyrosine Kinas Inhibitor and Fertility
2018
[2] Non-hematological Adverse Events of Imatinib in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP).
Journal of Applied Pharmaceutical Science (JAPS), 2015
[3] Non-hematological Adverse Events of Imatinib in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP)
Journal of Applied Pharmaceutical Science Vol, 2015
No relevant information.

● Open Special Issues

● Published Special Issues

● Special Issues Guideline

Health Subscription
E-Mail Alert
Health Most popular papers
Publication Ethics & OA Statement
History Issue
Health News
Frequently Asked Questions
Recommend to Peers
Recommend to Library
Contact Us
Disclaimer
Follow SCIRP Home About SCIRP Service Policies
Journals A-Z Journals by Subject Manuscript Tracking System Open Access
Books For Authors Translation & Proofreading Publication Ethics
Jobs Publication Fees Careers Preservation
Blog Special Issues Subscription Retraction
Submission System Login Sitemap Peer-Review Resources Frequently Asked Questions Advertising
Contact Us News Volume & Issue Privacy Policy
Copyright © 2006-2021 Scientific Research Publishing Inc. All Rights Reserved.